Bulletin "Veterinary biotechnology"

Veterynarna biotehnologija – Veterinary biotechnology, 2022, 40, 121-131 [in Ukrainian]. https://doi.org/10.31073/vet_biotech40-11

TARASOV O.A., e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.ZAKHAROVA O.M., e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.HUDZ N.V., e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Institute of Veterinary Medicine NAAS

KOLYCH N.B., PhD, Associate Professor, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

National University of Life and Environmental Sciences of Ukraine




Introduction. Erysipelothrix rhusiopathiae causes significant economic losses in pigproductionin Ukraine, EU and other countries. The study of the virulence factors of erysipelas causative agent, formation of specific immunity and its intensity does not lose relevance today because of antigenic variation and due to the direct impact on the effectiveness of preventive vaccination. Control of vaccine strains quality is the actual topic for research and neuraminidase is one of the main factors of the virulence of E. rhusiopathiae and its producing peculiarities have to be investigated.

The goal of the work wasto study the peculiarities of neuraminidase production of the swine erysipelas causative agent.

Materials and methods. The strains of the bacterium E. rhusiopathiae 27, 93, 149, 251, 419, 1689, 1893, 1933, M-2 VK, BP-2 var IVM, K, Ш and 5 pathogenic field isolates stored in the museum of the Institute of Veterinary Medicine were used. S.aureus ATCC 33592 was used as a positive control. Hottinger meat-peptone broth media (BHIB, BHIB/S), soy hydrolyzate (TSB, TSB/S), Feist medium, Feist medium with serum (SF/S) manufactured by HiMedia, India, were used for research according to the manufacturer’s recommendations. Preservative-free sterile bovine serum (Leucopol, Ukraine) was added to the medium after sterialization of 10% of the total volume of the medium. Lectin-mediated haemagglutination reaction was used to detect neuraminidase production according to standard protocol.

Results of research and discussion. Neuraminidase production was found in all studied strains and isolates of E. rhusiopathiae. As a result of the conducted researches it is established that neuraminidase has a low level of production before the beginning of the stationary phase of growth. The highest level of production was found between 16 and 24 hours from the beginning of incubation. The accumulation of the enzyme allows to perform the hemagglutination reaction with reliable test results. This feature distinguishes E. rhusiopathiae from some other neuraminidase-producing bacteria, such as hemolytic staphylococci. Table 1 shows the results. The best results of optimizing lectin-mediated hemagglutination using strains of E. rhusiopathiae K were obtained by incubating the reaction mixture for 30 minutes at 37±0.2°C.

As a result of the conducted researches it is established that the necessary concentration of neuraminidase accumulates in the culture fluid after 16 hours from the incubation beginning.

To determine the optimal pH for neuraminidase activity, a range of pH values from 5.0 to 8.0 was investigated. The optimal pH level was tested using 11 museum strains and pathogenic field isolates of E. rhusiopathiae. It was found that the optimal pH was within 7.1±0.1. Beyond these indicators, the sensitivity of the reaction decreases.

Conclusions and prospects for further research. The optimal nutrient media and reaction conditions for the qualitative detection of neuraminidase in hemagglutination were selected. A pH of 7.1±0.1 is the optimal range for producing a detectable amount of neuraminidase, as it is within the highest enzymatic activity of all E. rhusiopathiae strains and isolates studied.

The BHIB/S medium, according to the research results, provided the best accumulation of neuraminidase, and the addition of bovine blood serum in amount of 10% increases the production of neuraminidase and provides reliable test results.

Future studies will focus on obtaining new data and studying the virulence factors of the causative agent of swine erysipelas in order to improve approaches for the selection of strains for the production of a highly immunogenic vaccine.

Keywords: swine erysipelas, neuraminidase, virulence factor, nutrient media.


  1. Voronin, E.C. (1987). Roja Sviney [Swine erysipelas]. M.: NNIITE agroprom [in Russian].
  2. Gevedze, V.I., Androsik, N.N., & Lenkova, V.A. (2017). Prophylaktyka bolezney sviney na kompleksah [The prophylaxis of swine diseases on pig complexes]. Minsk [in Russian].
  3. Harada, T., Ogawa, Y., Eguchi, M., Shi, F., Sato, M., Uchida, K., et al. (2014). Phosphorylcholine and SpaA, a choline-binding protein, are involved in the adherence of Erysipelothrix rhusiopathiae to porcine endothelial cells, but this adherence is not mediated by the PAF receptor. Vet. Microbiol., 172, 216-222. doi: 10.1016/j.vetmic.2014.04.012.
  4. Shimoji, Y., Ogawa, Y., Tsukio, M., et al. (2019). Genome-Wide Identification of Virulence Genes in Erysipelothrix rhusiopathiae: Use of a Mutant Deficient in a tagF Homolog as a Safe Oral Vaccine against Swine Erysipelas. Infect Immun., 87(12), e00673-19. doi: 10.1128/IAI.00673-19.
  5. Wang, Q., Chang, B.J., & Riley, T.V. (2010). Erysipelothrix rhusiopathiae. Vet Microbiol, 140(3-4), 405-417. doi: 10.1016/j.vetmic.2009.08.012.
  6. Forde, T.L., Ratheesh, N.K., Harvey, W.T., et al. (2020). Genomic and Immunogenic Protein Diversity of Erysipelothrix rhusiopathiae Isolated From Pigs in Great Britain: Implications for Vaccine Protection. Front Microbiol., 11, 418. https://doi.org/10.3389/fmicb.2020.00418.
  7. Yoshihiro, Shimoji, Yohsuke, Ogawa, Manae, Tsukio et al. (2019). Genome-Wide Identification of Virulence Genes in Erysipelothrix rhusiopathiae: Use of a Mutant Deficient in a tagF Homolog as a Safe Oral Vaccine against Swine Erysipelas. Infect Immun., 12, e00673-19. https://doi.org/10.1128/IAI.00673-19.
  8. Borrathybay, E., Gong, F.-J., Zhang, L., & Nazierbieke, W. (2015). Role of surface protective antigen A in the pathogenesis of Erysipelothrix rhusiopathiae strain C43065. J. Microbiol. Biotechnol., 25, 206-216. https://doi.org/10.4014/jmb.1407.07058.
  9. Rostamian, M., Rahmati, D., & Akya, A. (2022). Clinical manifestations, associated diseases, diagnosis, and treatment of human infections caused by Erysipelothrix rhusiopathiae: a systematic review. Germs., 12(1), 16-31. https://doi.org/10.18683/germs.2022.1303.
  10. Opriessnig, T., Forde, T., & Shimoji, Y. (2020). Erysipelothrix Spp.: Past, Present, and Future Directions in Vaccine Research. Front Vet Sci., 7, 174. https://doi.org/10.3389/fvets.2020.00174.
  11. Wattrang, E., Eriksson, H., Albihn, A., & Dalgaard, T.S. (2021). Quantification of IgY to Erysipelothrix rhusiopathiae in serum from Swedish laying hens. BMC Vet Res, 6, Vol. 17(1), 111. https://doi.org/10.1186/s12917-021-02813-0.
  12. Makino, S.I., Yamamoto, K., & Murakami, S. (2018). Properties of repeat domain found in a novel protective antigen, SpaA, of Erysipelothrix rhusiopathiae. Microb. Pathog., 25, 6, 101-9.
  13. Makino, S.I., Yamamoto, K., & Asakura, H. (2011). Surface antigen, SpaA, of Erysipelothrix rhusiopathiae binds to Gram-positive bacterial cell surfaces. FEMS Microbiol. Lett., Vol. 186, (2), 313-317.
  14. Hofseth, K., Dalen, H., Kibsgaard, L., et al. (2017). Infectious tenosynovitis with bloodstream infection caused by Erysipelothrix rhusiopathiae, a case report on an occupational pathogen. BMC Infect Dis, 17, 12. https://doi.org/10.1186/s12879-016-2102-1.
  15. Hua, P., Liu, J., Tao, J., et al. (2015). Erysipelothrix rhusiopathiae-induced aortic valve endocarditis: case report and literature review. Int J Clin Exp Med., 8(1), 730-736.
  16. Shimoji, Y., et al. (2020). Development of a Multiplex PCR-Based Assay for Rapid Serotyping of Erysipelothrix Species. J Clin Microbiol., 58(6), e00315-20. https://doi.org/10.1128/JCM.00315-20.
  17. Janßen, T., Voss, M., Kühl, M., et al. (2015). Combinational approach of multilocus sequence typing and other molecular typing methods in unravelling the epidemiology of Erysipelothrix rhusiopathiae strains from poultry and mammals. Vet Res., 46(1), 84. https://doi.org/10.1186/s13567-015-0216-x.
  18. Ahmadi, P., Mansour, B., Haghparasti A.F., (2017). Isolation and Detection of Erysipelothrix rhusiopathiae and Its Distribution in Humans and Animals by Phenotypical and Molecular Methods in Ahvaz-Iran in 2015. Iran J Med Sci., 42(4), 377-383.
  19. Uchiyama, M., et al. (2017). Pathogenic characterization of Erysipelothrix rhusiopathiae Met-203 type SpaA strains from chronic and subacute swine erysipelas in Japan. J Vet Med Sci., 79(1), 18-21. https://doi.org/10.1292/jvms.16-0164.
  20. Ding Y., et al. (2015). Virulence determinants, antimicrobial susceptibility, and molecular profiles of Erysipelothrix rhusiopathiae strains isolated from China. Emerg Microbes Infect.,4(11), e69. https://doi.org/10.1038/emi.2015.

Download full text in PDF